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Abstract
Transmission lies at the interface of human immunodeficiency virus type 1 (HIV-1) evolution within and among hosts and
separates distinct selective pressures that impose differences in both the mode of diversification and the tempo of
evolution. In the absence of comprehensive direct comparative analyses of the evolutionary processes at different biological
scales, our understanding of how fast within-host HIV-1 evolutionary rates translate to lower rates at the between host level
remains incomplete. Here, we address this by analyzing pol and env data from a large HIV-1 subtype C transmission chain for
which both the timing and the direction is known for most transmission events. To this purpose, we develop a new
transmission model in a Bayesian genealogical inference framework and demonstrate how to constrain the viral
evolutionary history to be compatible with the transmission history while simultaneously inferring the within-host
evolutionary and population dynamics. We show that accommodating a transmission bottleneck affords the best fit our
data, but the sparse within-host HIV-1 sampling prevents accurate quantification of the concomitant loss in genetic
diversity. We draw inference under the transmission model to estimate HIV-1 evolutionary rates among epidemiologically-
related patients and demonstrate that they lie in between fast intra-host rates and lower rates among epidemiologically
unrelated individuals infected with HIV subtype C. Using a new molecular clock approach, we quantify and find support for
a lower evolutionary rate along branches that accommodate a transmission event or branches that represent the entire
backbone of transmitted lineages in our transmission history. Finally, we recover the rate differences at the different
biological scales for both synonymous and non-synonymous substitution rates, which is only compatible with the ‘store and
retrieve’ hypothesis positing that viruses stored early in latently infected cells preferentially transmit or establish new
infections upon reactivation.
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Introduction
HIV evolutionary analyses generally focus on either within-host
dynamics or on among-host epidemiological processes [1]. The
rapid evolutionary rate of HIV allows the virus to accumulate
significant sequence divergence over the time course of a single
infection, ensuring that within-host HIV populations can escape
both considerable immune and drug selective pressure. Across
multiple infections, however, these selective dynamics and within-
host evolutionary arms race do not appear to strongly impact the
mode of HIV diversification, as multiple co-circulating lineages
generally reflect more neutral epidemiological dynamics [2]. The
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mechanisms involved in HIV transmission are key to this
distinction and they have received a great deal of attention due
to their importance for the design of preventive strategies (e.g. [3]).
Although transmission generally imposes a strong bottleneck on
HIV within-host populations [4,5], no clear phenotypic constraints
appear to act on transmission apart, perhaps, from co-receptor
usage, and a multitude of viral phenotypical aspects are only
loosely associated with enhanced transmission [6].
In addition to studies characterizing viral founder populations,
phylogenetic studies also take great interest in sequence data
sampled across multiple infections. Molecular phylogenetics
represents a popular approach to elucidate transmission links in
a wide variety of situations, including nosocomial transmission
from health care workers [7,8], mother-to-child transmission [9],
sexual transmission [10,11], parenteral transmission [12] and even
criminal transmission [13,14]. Its use as a forensic tool has led to a
critical appraisal of viral phylogenetics e.g. [15,16], and in this
respect, known transmission histories may provide valuable data to
evaluate the performance of the evolutionary reconstruction
methods. By comparing inferred clustering patterns with the
known phylogenetic relationships in a Swedish transmission chain,
Leitner et al. [17] were the first to demonstrate that phylogenetic
estimates were generally consistent with the transmission history,
provided the evolutionary model accounts for rate variation. A
more recent analysis of an HIV transmission cluster involving 9
patients also presented phylogenetic reconstructions that were
largely compatible with the known transmission history, except for
one particular transmission link that appeared to be confounded
by multi-drug resistance patterns in the pol gene [18]. Whereas
Leitner et al. examined topological differences between a single
viral and transmission tree, the more recent study took a somewhat
different perspective on compatibility and examined whether any
conflict arises when attempting to superimpose the host transmis-
sion history onto the viral phylogeny. This was motivated by the
fact that different viral evolutionary trajectories can be embedded
within a particular host transmission tree, akin to gene trees and
their containing species trees [19].
In addition to confirming transmission links, the question has
also been raised to what extent transmission direction and even
transmission times can be ascertained through phylogenetic
approaches. The former may be inferred through paraphyletic
clustering of the source viruses with respect to those of the
recipient, which requires adequate sampling of the viral diversity
within both source and recipient [20] or samples from the source
both before and after transmission [18]. To explore the temporal
dimension of viral transmission, phylogenetic trees need to be
calibrated in time units. This is accommodated by the incorpo-
ration of molecular clock models in phylogenetic inference and has
proven useful to test hypotheses on HIV-1 and HCV transmission
[21]. Applications to next-generation sequencing data have further
exploited time-measured trees to provide genetic estimates of dates
of HIV infection [22], although it needs to be acknowledged that -
even when a bottleneck can generally be assumed - the
transmission may have occurred anywhere between the divergence
from the source and the most recent common ancestor of the
recipient viruses [23].
The ability to estimate divergence times and evolutionary rates
from time-stamped sequence data has provided a historical
perspective on the emergence of different viruses (e.g. [24]) and
resulted in detailed investigations into the tempo of evolution at
different evolutionary scales [25,26]. Such studies also led to the
suggestion that HIV evolutionary rates may be higher within hosts
compared to among hosts. Although few attempts have been made
to quantify such differences, different hypotheses have been put
forward to explain a potential rate discrepancy [27] and modeling
efforts have been undertaken to examine them [28]. From an
evolutionary biology perspective, it is difficult to explain such
differences in the tempo of evolution at the different scales, and
similar to differences in the mode of phylogenetic diversification,
they may be dependent on how transmission is linked to within-
host evolutionary dynamics. A rate mismatch may arise from the
preferential transmission of stored virus, which will be ancestral to
the currently circulating diversity in the source patient, and this
will result in the accumulation of fewer substitutions between hosts
(‘store and retrieve’) [28,29]. This is in line with a recent
phylogenetic study that provided a genome-wide quantification
of rate differences within and among-host, and although based on
limited within-host data, the consistently-elevated rates across the
entire genome seem to support the hypothesis that HIV strains
that are less adapted to the host have an advantage during
transmission [30]. Alternatively, it has been proposed the within-
host adaptive process will have little impact on between host
evolutionary rate estimates because many transmissions will occur
early in infection before the host mounts effective immune
responses (‘stage-specific selection’) [27,31]. Finally, Herbeck et
al. [32] explain the rate mismatch by invoking frequent reversion
of adaptive mutations when virus enters a new host mounting
different immune responses (‘adapt and revert’).
Here, we present a new Bayesian genealogical inference
approach that reconstructs within-host viral evolution and
population dynamics for different individuals linked in a trans-
mission cluster. At the core of this approach lies a transmission
model that requires viral genealogies to be compatible with a
timed history of transmission events from a coalescent perspective.
Specifically, the model constrains the coalescent time for the
source and recipient viral population to be older than the
transmission event and assumes a host transition in the viral
genealogy upon transmission. This approach (i) further relaxes
requirements for topological compatibility between host and viral
Author Summary
Since its discovery three decades ago, the HIV epidemic
has unfolded into one of the most devastating pandemics
in human history. When HIV replication cannot be
completely inhibited, the fast-evolving retrovirus continu-
ously evades intra-host immune and drug selective
pressure, but diversifies according to more neutral
epidemiological dynamics at the interhost level. Limited
evidence suggests that the virus may evolve faster in a
single host than in a population of hosts, and various
hypotheses have been put forward to explain this
phenomenon. Here, we develop a new computational
approach aimed at integrating host transmission informa-
tion with pathogen genealogical reconstructions. We
apply this approach to comprehensive sequence data sets
sampled from a large HIV-1 subtype C transmission chain,
and in addition to providing several insights into the
reconstruction of HIV-1 transmissions histories and its
associated population dynamics, we find that transmission
decreases the HIV-1 evolutionary rate. The fact that we also
identify this decline for substitutions that do not alter
amino acid substitutions provides evidence against
hypotheses that invoke selection forces. Instead, our
findings support earlier reports that new infections start
preferentially with less evolved variants, which may be
stored in latently infected cells, and this may vary among
different HIV-1 subtypes.
HIV-1 Evolutionary Rate within and among Hosts
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evolutionary history, (ii) makes no assumption about transmission
bottlenecks, and (iii) makes more explicit use of the temporal
dimension in viral evolutionary reconstructions from serially-
sampled data. Importantly, the transmission constraints and
associated parameterization of transmission times allow partition-
ing of the viral genealogy into patient-specific evolutionary
trajectories, each informing the parameters of an overall within-
host demographic model. We apply this approach to new clonal
HIV-1 subtype C data from a previously-described [18], but
extended heterosexual transmission chain. Before applying the
model, we test molecular clock models and evaluate the
compatibility of the viral evolutionary history with the transmis-
sion model constraints. We subsequently explore the model’s
ability to estimate transmission bottlenecks and transmission times,
and use it to quantify evolutionary rates at the interface of within
and among-host HIV evolution. Our analyses clearly indicate that
transmission decreases HIV-1 evolutionary rates, and since this is
the case for both synonymous and non-synonymous substitutions,
the findings are consistent with the hypothesis of preferential
transmission of ancestral virus.
Results
Sequence data
We amplified and sequenced partial pol and env regions for
multiple clones from 11 patients in a previously-studied HIV-1
subtype C transmission chain [18]. Our clonal sampling includes
sequences from additional time points for six out of nine previously
described patients as well as sequences from two newly identified
patients in the transmission cluster (K and L; Figure S1). Written
informed consent was obtained from each patient [18]. Patient A
and B represent the earliest infected patients in this cluster, but the
time and direction of transmission between these two patients has
not been clearly established. For the other transmission events,
patient interviews and clinical data were able to demarcate a
relatively narrow time interval for transmission (see Table S1).
Table S2 lists the sampling date, the number of pol and env clonal
sequences obtained for each sample and the sample viral load (if
known).
Bayesian genealogical inference
Testing molecular clock models. Because the compatibility
constraints we introduce as part of the transmission model
condition on divergence times for the viral lineages, we first
determined the most appropriate molecular clock model using a
standard Bayesian genealogical reconstruction with a flexible
coalescent prior (the Skyride model, [33]). We compared strict and
relaxed molecular clock models [34] using log marginal likelihoods
estimated by recent implementations of path sampling (PS) and
stepping-stone (SS) sampling [35,36] (Table S3). For both the pol
and env data sets, uncorrelated relaxed molecular clocks provide a
better model-fit compared to the strict molecular clock. Consistent
with general findings in previous analyses [36], a model that
considers a lognormal distribution to model rate variation among
lineages consistently outperforms a model using an exponential
distribution. We therefore performed all further analysis using this
relaxed clock parameterization.
Compatibility between viral evolutionary history and
transmission history. Before assuming coalescent compatibil-
ity under the transmission model, we investigated to what extent
the viral genealogy meets these constraints using a standard tree
prior. The compatibility constraints constitute an essential part of
the transmission model and enforce source and recipient lineages
to coalesce before transmission time while superimposing the
source-recipient transition onto the relevant viral lineages to
ensure that the genealogy follows the known chain of transmission
events (as illustrated in Figure 1; cfr. Methods). We performed a
Bayesian genealogical inference using a flexible tree prior and
summarize, for each transmission event, the frequency by which
the relevant viral coalescent patterns are indeed compatible with
the timed order of transmissions with Bayesian inference using
Markov chain Monte Carlo (MCMC) analysis. These posterior
compatibility probabilities, together with molecular clock and
divergence time estimates are listed in Table 1 for both pol and env.
Focusing on pol, we find maximum or close to maximum
posterior compatibility probability for 7 out of 10 transmission
events. To examine the incompatible coalescent patterns in more
detail, we summarized a maximum clade credibility (MCC) tree
and superimposed the transmission intervals in Figure 2. This
reveals that an anomalous clustering pattern and not an
inappropriate divergence time is responsible for the incompatibil-
ity for the patient B to H transmission event. The patient I cluster
is nested within the patient H diversity, and following the
transmission from patient B to patient I on the branch ancestral
to I and H, the virus needs to remain in patient I up to its specific
cluster. Therefore, the transmission from patient B to patient H,
which would have to occur along the same branch as the B to I
transmission, cannot be realized anymore.
Because the divergence time for patient B and patient I lineages
is relatively close to the B?I transmission time, this coalescence
event might occasionally be estimated after the transmission,
resulting in a imperfect compatibility probability of 0.78. Although
topologically consistent with the transmission history, the mean
coalescence time for patient C and D lineages is estimated after the
relevant transmission interval and only a small fraction of the
posterior density for this estimate appears to be before the
transmission time, resulting in a compatibility probability of 0.01.
To test whether drug selective pressure had any influence on
compatibility, we performed the same analysis excluding positions
associated with drug resistance [18]. Although this has little impact
on most of the posterior compatibility estimates (Table 1), patient
H and patient I viruses now form two reciprocally monophyletic
clusters in the MCC tree and, as opposed to the unexpected
paraphyletic clustering in Figure 2, this different clustering results
in a somewhat higher compatibility for the transmission from
patient B to H (see Figure 3). The evolutionary rate estimate is
slightly lower than that for the original pol dataset (Table 1), which
likely reflects the removal of positions at which substitutions can
become rapidly fixed due to the drug selective pressure. As a
consequence, some divergence times may also be slightly older,
which may explain the somewhat higher compatibility probability
for transmission from patient C to D, as well as for patient B to H
(Figure 3).
Although the env compatibility is largely consistent with pol,
notable exceptions exist. In particular, the B-H coalescent patterns
are now fully compatible with the transmission history, and the env
MCC tree (Figure 4) suggest that this results from a remarkable
difference in clustering between patient B, H and I viruses. In this
tree, both patient H and I viruses independently diverge from a
patient B lineage and are not more closely related to each other
anymore. The coalescent time for patient I and B lineages is now
almost fully compatible with the known transmission time. For
both the B?I and the original transmission event however, which
either occurred from patient A to B or vice versa, there is now far
less compatibility for either possible scenario, which results from a
too recent MRCA for the relevant lineages relative to the
transmission time (Figure 4). The compatibility probability for
the C?D transmission is also impacted by a too recent coalescent
HIV-1 Evolutionary Rate within and among Hosts
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Figure 1. A hypothetical transmission chain and viral genealogy for 4 patients. For each transmission event, we show an upper and lower
boundary for the transmission event. The viral lineages within each each patient are represented by a particular branch color, while the transmission-
associated host transitions in the viral genealogy are depicted using a color gradient. Whereas the viral genealogy is compatible with transmission
from P1 to P2 and P2 to P3, independent of the number of lineages transmitted, the most recent common ancestor for the P3 and P4 lineages is too
recent to be compatible with the respective transmission event.
doi:10.1371/journal.pcbi.1003505.g001
Table 1. Molecular clock estimates and compatibility probabilities for the pol and env sequences.
pol pol excluding DRMs2 env
CA?B/CB?A
1 0.98/0,98 0.94/0.94 0/0
CA?F 1.00 1.00 1.00
CF?G 1.00 1.00 1.00
CB?C 1.00 1.00 0.99
CB?H 0 0.30 1.00
CB?I 0.78 0.36 0.99
CC?D 0.01 0.18 0.18
CC?E 1.00 1.00 1.00
CC?L 1.00 1.00 1.00
CE?K 1.00 1.00 1.00
evolutionary rate (95% HPD) 4.75 (3.98–5.54) 4.39 (3.67–5.11) 7.40 (6.36–8.44)
coefficient of variation (95% HPD) 0.53 (0.40–0.66) 0.47 (0.33–0.61) 0.55 (0.42–0.67)
tMRCA (95% HPD) 16.95 (16.53–17.44) 16.99 (16.54–17.49) 16.45 (16.10–16.80)
Compatibility is expressed as the proportion of trees in the posterior sample that is compatible with the indicated transmission event after removal of 10% as burn-in.
The mean evolutionary rate and highest posterior density (HPD) intervals are expressed as the number of nucleotide substitutions (1023) per site per year. The
coefficient of variation represents the scaled variance in evolutionary rate among lineages. The time to the most recent common ancestor (tMRCA) represents the time
since the most recent sampling date (24/03/2006), and is expressed in years.
1The percentage of sampled genealogies with an entirely compatible coalescent history (C) are listed for the transmission histories assuming A as the original source
(A?B) as well as B as the original source (B?A).
2DRMs =drug resistance mutations. See [18] for an overview of the removed positions.
doi:10.1371/journal.pcbi.1003505.t001
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time of the relevant viral lineages, but to the same extent as for the
pol analysis excluding drug resistance mutations.
Within-host dynamics, transmission bottleneck and
transmission times under the transmission model. In
addition to the compatibility constraints, the transmission model
we develop as part of this study also specifies a within-host
coalescent model with shared parameters across all patients,
except maybe for the source (cfr. Methods). This can be
implemented instead of a standard coalescent tree prior because
the transmission times, which are estimable parameters con-
strained by the transmission interval boundaries, demarcate the
patient-specific trajectories and their associated coalescent rates
(cfr. Figure 1). We consider three simple parametric coalescent
models: a constant population size model, an exponential growth
and logistic growth model, with only the latter two accommodat-
ing a transmission bottleneck. To identify the most appropriate
coalescent prior for the within-host population dynamics, we again
use PS and SS estimates of the log marginal likelihood (Table S4).
For both the pol and env data sets, a model with transmission-
associated bottleneck consistently yields higher log marginal
likelihoods than the constant population size model. The logistic
growth model offers a better model fit than an exponential growth
model in pol but this is not reproduced by the env analysis.
This model-fit evaluation supports a transmission bottleneck
and suggests a relatively rapid increase in relative genetic diversity
that levels off later in infection. The fact that we can capture signal
for these dynamics is remarkable given the relatively sparse
sampling of within-host diversity through time, in particular close
to transmission, and the fact that treatment may impact genetic
diversity. For these reasons, it is not surprising that it remains
difficult to accurately estimate the overall transmission bottleneck
in our transmission chain using the logistic growth model. Using a
constant (between 0 and 1) b(1,1) prior for the ancestral proportion
parameter, which quantifies the fraction of diversity transmitted
from the source, we arrive at posterior estimates 0.32 [0.21–0.44]
and 0.26 [0.00–0.70] for pol and env respectively. These estimates
Figure 2. Maximum clade credibility tree for pol. Both tips and internal branches are colored according to the patient in which the viral lineages
are hypothesized to reside (cfr. legend on the left). For branches that cross a transmission interval, the part up to the interval is assigned to the source
patients. For posterior support values for each node, we refer to Figure S2. The transmission intervals are represented by the grey boxes. Dashed red
circles indicate the topological and coalescent incongruences. For the C?D coalescent event, the posterior marginal density of the tMRCA estimate is
plotted over the corresponding node in greyshade. Only a lower limit of the transmission interval is known for the A<B transmission. For
transmissions B?C, F?G, C?E, C?L and E?K the most recent boundary of the transmission interval (almost) equals the first sampling date.
doi:10.1371/journal.pcbi.1003505.g002
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are unrealistically high compared to previous population genetic
studies reporting on diversity loss at transmission [4] or single
genome amplification studies demonstrating that HIV infections
are generally initiated by a single or only a few variants [37].
Given the lack of clear bottleneck signal in our sampling, we can
formalize previous knowledge as a prior distribution on the
ancestral proportion and specify an increasingly higher prior
probability towards small proportions using a b[1,10] and
b[1,100] distribution. As expected, the corresponding posterior
estimates returned increasingly lower ancestral proportions (e.g.
for env the mean decreases from 0.26 over 0.08 to 0.02 for b[1,1],
b[1,10] and b[1,100] respectively).
Because the transmission intervals we specify are generally
rather narrow relative to the sampling density through time (e.g.
for A?F, Figures 2 and 4), the transmission times are likely to be
sampled uniformly from the known interval. However, occasion-
ally we can find evidence that genealogical divergence times may
also impact the transmission time estimates. For C?L for
example, a very large time interval has been specified reflecting
the uncertainty on the transmission time, in which case the lower
boundary is determined by the divergence time between the
source and recipient lineages. On the other hand, the estimates of
divergence times relative to transmission times may also be
affected by the bottleneck size. When considering the difference
between the transmission time estimate and the time estimate for
the MRCA of the recipient viral population for C?E in env, we
obtain values of 20.05 (20.68,0.24), 0.04 (20.43,0.26) and 0.11
(0.00,0.30) years for the b[1,1], b[1,10] and b[1,100] priors
Figure 3. Maximum clade credibility tree for pol after exclusion of the same drug resistance associated positions as in [18]. Tips and
internal branches are colored according to the states’ posterior probability as estimated using a non-reversible discrete asymmetric trait analysis with
the patients as discrete states [67,68]. Both tips and internal branches are colored according to the patient in which the viral lineages are
hypothesized to reside (cfr. legend on the left). For posterior support values for each node, we refer to Figure S3. The black dotted circle indicates the
node responsible for the higher compatibility of the B?H transition. Like the increased C?D compatibility, this results from the lower evolutionary
rates that lead to somewhat older divergence time estimates. A) The divergence time between the patient B and I lineages is older than the upper
bound of the B?I transmission interval. Following the B?I host transition, B?H cannot be compatible any more. B) When the B-I divergence time is
estimated after its respective transmission, the viral genealogy is inferred to be incompatible with the B?I transmission, and no transition into
patient I is assumed. However, because the same node also represents the B-H coalescence time and this is in agreement with the compatibility
constraints, the fair amount of too recent divergence time estimations for the B-I lineages results in 30% B?H compatibility.
doi:10.1371/journal.pcbi.1003505.g003
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respectively. The negative difference represents a MRCA of the
recipient population that is older than the transmission time, and
hence implies transmission of multiple variants, whereas the
positive values represent transmission of a single lineage as
expected by the prior specification preferring a transmission
bottleneck. This reflects the potential interaction between bottle-
neck size and transmission/divergence times, but in the absence of
strong prior specification, the extent to which this can occur will
again depend on sampling intensity.
Transmission decreases HIV-1 evolutionary rates
Our sampling is not very informative about the transmission-
associated bottleneck size, but it does provide a unique opportu-
nity to investigate the impact of transmission on evolutionary rates.
Although formal evaluations are sparse, evolutionary rates among
hosts are suggested to be lower than evolutionary rates between
hosts [27,28,30]. To investigate this using our data, we separately
estimated within-host and between host evolutionary rates for both
pol and env. The within-host estimate was obtained using a
Bayesian hierarchical phylogenetic model (HPM) fit across
patients for which multiple samples are available. The HPM
model posits patient-specific evolutionary rate parameters, but
allows sharing of evolutionary rate information across patients
through a hierarchical prior specification. We report estimates of
the mean of the population-level (hierarchical) distribution as the
within-host evolutionary rate. An among-host evolutionary rate for
closely related patients was obtained using a transmission model
analysis that only considered a single sample per patient (cfr.
Methods). In addition, we compared these inferences with
evolutionary rate estimates from a data set representing epidemi-
ologically-unrelated patients infected with subtype C for the same
genome regions (cfr. Methods). Despite the uncertainty associated
with evolutionary rate estimates, this reveals a clear rate decrease
from small (within-host) to large (among-host) evolutionary scales
Figure 4. Maximum clade credibility tree for env. Both tips and internal branches are colored according to the patient in which the viral
lineages are hypothesized to reside (cfr. legend on the left). For branches that cross a transmission interval, the part up to the interval is assigned to
the source patients. For posterior support values for each node, we refer to Figure S4. The transmission intervals are represented by the grey boxes.
Dashed red circles indicate the coalescent incongruences. For the A<B and C?D coalescent event, the posterior marginal density of the tMRCA
estimate is plotted over the corresponding node in greyshade. Only a lower limit of the transmission interval is known for the A<B transmission. For
transmissions B?C, F?G, C?E, C?L and E?K the most recent boundary of the transmission interval equals the first sampling date.
doi:10.1371/journal.pcbi.1003505.g004
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(Figure 5), with an intermediate rate for the epidemiologically-
related patients in the transmission chain. For both pol and env, we
observe about a twofold decrease in evolutionary rate among
epidemiologically-unrelated patients compared to the within-host
evolutionary rate.
The patients in the subtype C transmission chain have received
antiretroviral therapy for a substantial part of the period between
the first and last sample (see Figure S1), and this can affect viral
evolutionary rates in different ways [18,38]. Because the rate
estimate for the transmission chain relies on the samples before or
only shortly after treatment initiation for each patient, we do not
expect a considerable effect on the among-host evolutionary rate.
To examine whether treatment biases the within-host evolutionary
rates however, we compared our rates to estimates for a control set
of longitudinally sampled therapy-naive patients (cfr Methods)
using a Bayesian HPM approach with fixed-effects [39]. This does
not support any rate differences (see Table S5), suggesting that
therapy does not confound our comparison within and between
hosts. Because the control data sets include sampling over different
times during infection, we took the opportunity to also stratify
these patients into an ‘early’ and ‘chronic’ group, based on sample
availability before or after the first year of infection, in order to test
for stage-specific evolutionary rates. No substantial rate difference
between both groups was detected (see Table S5), which argues
against evolutionary rate differences due to stage-specific selection.
To test more explicitly that transmission decreases evolutionary
rates, we develop a new molecular clock approach that allows for
rate variation according to a relaxed molecular clock model but
also incorporates fixed effects to quantify a difference in rate along
a specified subset of branches (cfr. Methods and Figure S5). We
applied this model within the transmission chain framework in two
different ways. First, we specified an estimable rate effect on the
branches to which a transmission event can be unambiguously
assigned and we estimate the support for a lower rate on these
branches using ln Bayes factors (BFs). Using this approach, we find
about a twofold lower rate on the branches that accommodate a
transmission event in the subtype C transmission chain for both pol
and env with a strong ln BF support (Table 2). We also extended
the fixed effects to the complete branch set representing the
transmitted lineage in the chain as opposed to the within-host
branches that can be generally considered as evolutionary dead-
ends (see Figure S5). This results in similar rate differences and
Figure 5. Violin plot representation of the pol and env within and between-host evolutionary rates. Only patients for which samples for
more than one time point are available were used for the within-host analysis. The ‘within’ host label represents the HPM estimate of the mean within
host evolutionary rate of all patients. Likewise, the ‘linked’ between host label marks the direct estimate of the between host evolutionary rate. For
the latter, only the first available sample of each patient was used. The ‘unlinked’ between host labels denotes the rate estimates obtained with the
skyride prior for the pol and env regions of the epidemiologically unlinked subtype C sequences that overlap with our clonal data sets. The means of
each rate estimate are connected by a black line. Numbers between brackets indicate the fold decrease of the mean relative to the within host mean
rate estimate. All rates are in units of nucleotide substitutions per site per year * 1023.
doi:10.1371/journal.pcbi.1003505.g005
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associated ln BF support and complements our comparison of
intra-host and inter-host evolutionary rates in providing statistical
evidence for a slower among-host ‘trunk or backbone’ rate in the
transmission chain compared to lineages that do not get
transmitted. We note that this rate difference is not enforced by
the transmission constraints because we get consistent results when
using a flexible coalescent prior (the Bayesian skyride model, Table
S6), even though env shows a somewhat less pronounced rate
difference.
The different hypotheses that have been put forward to explain
rate differences within and among hosts have different expecta-
tions concerning synonymous (mS ) and non-synonymous (mN )
substitution rates [28]. Whereas ‘store and retrieve’ is expected to
affect mS and mN rates in a similar way, ‘adapt and revert’ and
‘stage-specific selection’ are predicted to have a greater influence
on non-synonymous mutations and their substitution rates.
Moreover, the latter two hypotheses may also imply a more
pronounced rate decrease for non-synonymous substitutions in env
because of the major immunological pressure it experiences. To
assess these predictions for our data, we resort to recent techniques
to map codon substitutions [40] and employ them to obtain
posterior estimates of mS and mN (see Methods). Comparing the mS
and mN estimates for both pol and env to the overall substitution
rates (Figure 5), we consistently find a similar rate decrease over
the different evolutionary scales, and similar decreases for both pol
and env. As expected for approximately silent substitutions, mS
estimates are highly similar between pol and env for the same
evolutionary scale (they are the only estimates with the same Y-
axis scale for the corresponding pol and env panels in Figure 5).
Estimates of mN on the other hand are much higher for env due to
stronger immune pressure and relaxed constraints in this gene
region.
Discussion
In this study, we present a novel transmission model in a
Bayesian genealogical inference framework that focuses on time-
calibrated viral evolutionary histories and requires such genealo-
gies to be compatible with a known transmission history. Before
applying the model to estimate HIV-1 evolutionary rates, we
investigate the compatibility assumptions on new clonal data from
a subtype C transmission chain and assess the model’s potential to
estimate transmission bottlenecks. We consider viral genealogies to
be compatible with a transmission history if the viral lineages from
the source and recipient coalesce before the time of transmission
and if the host transitions can be superimposed onto the genealogy
according to the time-ordered chain of transmission events. This
approach follows gene-species tree thinking [19] and relaxes the
assumption that viral and transmission trees need to be a perfect
match, but explicitly incorporates temporal constraints instead.
The compatibility concept we introduce here, as well as the
violations we identify in our data, are important considerations for
phylogenetic studies that assess transmission linkage. Conditioning
on the contact tracing information being correct, the major source
for the 2 to 3 incompatible transmission events we observe for both
pol and env appears to be a too recent divergence time estimate for
the source-recipient lineages, as exemplified by the C–D coales-
cence patterns, and not anomalous clustering. In this respect, it is
important to note that high compatibility statistics are only expected
if a considerable ancestral divergence (or pre-transmission interval
[41]) exists for each transmission event. If the source and recipient
lineages coalesce almost immediately before the time of transmis-
sion, the stochasticity of the substitution process and the stochastic
error in the divergence time estimates will inevitably result in
credible intervals for the divergence time of source-recipient
lineages that overlap with the upper boundary for the transmission
time. However, since the ancestral divergence is generally
pronounced in transmission chains [41], the fact that we do not
observe high compatibility for these transmission events may be due
to the same reason we invoke for the lower inter-host evolutionary
rates. A preferential transmission of ancestral viruses may in fact
result in more similar source-recipient lineages than expected based
on their transmission time and bias their divergence time estimates
towards more recent times (see Figure S6). The only instance of
incompatibility that appears to result from a clustering issue involves
the clustering of patient B,H and I lineages in pol. The marked
difference with the clustering for env might have resulted from a
pattern of convergent evolution leading to higher similarity between
patient I and patient H virus in pol. An analysis excluding the
positions associated with drug resistance indicated that drug
selective pressure may at least have been responsible for the
unexpected paraphyletic clustering of patient I with respect to
patient H, but their divergence time is still too recent to be
compatible with patient B as a source for both these patients. We
note that convergent evolution due to drug selective pressure also
induced incompatible clustering in the original analysis of the
population sequences from this transmission chain [18]. However,
this concerned the viruses from patients F and G, and the
convergent substitution patterns involved may have a lower impact
on our analyses because we use longer and therefore more
informative clonal sequences. Although we attempted to exclude
recombinant sequences from our analysis, we note that undetected
recombination within a gene region may also be responsible for
incompatibly between the viral genealogy and transmission history.
Also relevant to phylogenetic investigations of viral transmission
is the ability to infer transmission direction. A recent study of HIV
Table 2. Evolutionary rate estimates and support for the fixed effect in the mixed effects clock model.
Fixed effects pol env
rate lnBF rate lnBF
transmission branches 1.82 (1.00,2.76) 7.50 3.95 (1.99,6.01) 6.40
within-host branches 4.28 (3.40,5.25) 8.41 (6.68,10.23)
transmitted lineage branches 2.21 (1.57,2.99) .7.50 3.80 (2.32,5.20) .6.29
within-host branches 5.07 (4.02,6.21) 10.37 (8.06,12.76)
The mean evolutionary rate and highest posterior density (HPD) intervals are expressed as the number of nucleotide substitutions (1023) per site per year. The Bayes
factor (BF) is computed as the posterior odds over the prior odds that the rate for the transmission branches or transmitted lineage branches is smaller than the within
host-rate.
doi:10.1371/journal.pcbi.1003505.t002
HIV-1 Evolutionary Rate within and among Hosts
PLOS Computational Biology | www.ploscompbiol.org 9 April 2014 | Volume 10 | Issue 4 | e1003505
transmission in two criminal cases suggested that transmission
direction can be deduced from paraphyletic relationships that
show recipient virus clades nested within the larger diversity of the
source virus population [20]. We demonstrate that such relation-
ships can be easily reconstructed in a rooted phylogeny when
source samples are available before and after transmission. In the
absence of such samples from the source, however, both the source
and recipient diversity may need to be sampled close to
transmission to be able to recover paraphyletic relationships. We
show that different gene regions are not necessarily consistent in
revealing recipient sub-clusters within a source clade. For example,
a paraphyletic relationship is reconstructed for the F?G
transmission in pol but not in env. In source F, a selective sweep
in the env region, which is the dominant target for immune
selective pressure, might already have erased the paraphyletic
structure. Indeed, within-host HIV phylogenies generally have a
strong temporal structure [42] and the continual strain turnover
will reduce the probability of recovering source-recipient para-
phyletic relationships. In addition to the differential impact of
selective pressure (e.g. drug selective pressure in pol and immune
selective pressure in env) and incomplete lineage sorting effects in
the two genome regions that may be largely unlinked due to
recombination, also experimental aspects leading to non-propor-
tional representation of variants could explain the general
differences we observe among the two gene regions.
The transmission model incorporates a coalescent prior that
models the within-host population dynamics for each patient
starting from transmission from its respective source. Although not
the focus of our study, we demonstrate that a model incorporating
a transmission bottleneck with subsequent logistic growth in
relative genetic diversity fits our data best. Accurately quantifying
the bottleneck, however, remains challenging and requires more
dense sampling, in particular close to transmission. In the absence
of such data, prior information on the bottleneck size may be
incorporated, which in our case indicates that the bottleneck size
parameter may interact with the relative timing of the transmission
and recipient MRCA, provided recipient diversity is sampled close
to transmission. The latter is likely to be a general requirement to
accurately estimate HIV-1 infection dates from recipient coales-
cent times [22]. Intensive sampling throughout transmission will
not only assist in estimating transmission times or quantifying
bottlenecks, but it may also help to resolve whether the bottleneck
results from a single variant being transmitted as opposed to the
outgrowth of a single lineage from multiple transmitted viruses in
the recipient [43]. In addition to more samples, the genealogical
inference may also benefit from a more detailed characterization
of the diversity within each sample. Nowadays this can be
efficiently pursued using next-generation sequencing (NGS)
platforms, although this would result in shorter read lengths than
the clonal sequences we obtained here. Finally, conventional (RT-
)PCR followed by either molecular cloning or NGS may both
suffer from a non-proportional representation of sequences due to
the re-sampling of only certain templates. This as well as other
confounders can be avoided by using single genome amplification
followed by direct sequencing of the amplicons [44]. We note that
the availability of more comprehensive sampling may not only
better inform the current model but also stimulate the develop-
ment of extensions such as patient-specific coalescent parameter-
izations as well as more complex coalescent models, perhaps in a
hierarchical framework [39].
Using the transmission model, we scrutinize HIV-1 evolutionary
rates in the subtype C transmission chain and find an intermediate
rate compared to within-host evolution on the one hand and
evolution among epidemiologically unrelated individuals on the
other hand. This suggest that the more transmissions in the HIV-1
evolutionary history, the slower the evolutionary rate, which may
be consistent with the different hypotheses put forward to explain a
rate mismatch at different HIV-1 evolutionary scales. The subtype
C transmission chain encompasses 15 years of HIV evolution and
10 transmission events, while the subtype C evolutionary history
for 81 sequences from unrelated patients encompasses about 50
years of HIV evolution but at the very least more than 8 times the
number of transmission events. The fact there are far more
transmission events and therefore more opportunity for transmis-
sion-associated rate decrease in the latter explains why we find the
lowest evolutionary at this scale. We test the transmission-
associated rate decline more explicitly by applying a new
molecular clock model that allows quantifying a different rate
for the branches that accommodate a transmission event. In
agreement with the twofold lower rate among epidemiologically-
unrelated patients compared to within-host evolutionary rates, we
demonstrate a similar rate difference between branches accom-
modating a transmission event or branches representing the entire
transmitted lineage compared to background within-host evolution
in the viral genealogy for both pol and env. This suggests that
lineages that avoid accumulating particular substitutions within
hosts, perhaps those resulting from the evolutionary arms race, do
not compromise their transmissibility and will consequently be
characterized by a lower divergence rate.
Evidence for a rate difference within and among hosts across the
entire genome was recently interpreted as support for the ‘store
and retrieve’ hypothesis [30]. Indeed, it seems unlikely that the
selection forces invoked by both the ‘stage-specific selection’
hypothesis and the ‘adapt and revert’ hypothesis operate strongly
across the entire genome. Our study also finds similar differences
in two different genome regions, but more importantly, we provide
evidence for a similar decline in both synonymous and non-
synonymous substitution rates. This argues more directly against
hypotheses based on selective dynamics whereas it is compatibility
with the ‘store and retrieve’ hypothesis. We acknowledge that
synonymous substitutions are not necessarily selectively neutral,
for example due to codon usage bias and secondary RNA
structure, but the selection effect will still be considerably weaker
on silent versus replacement changes [45]. It is therefore not
surprising that we find similar synonymous substitution rates for
both pol and env at the same evolutionary scale despite very
different non-synonymous rates. By focusing on synonymous
substitutions, we also avoid having to compare rates for a subset of
branches, such as the internal branches [30], which, unlike
external or tip branches, are less likely to represent transient
(slightly) deleterious mutations that will be eliminated by purifying
selection [46,47]. Whereas [30] found a more pronounced rate
difference in the env gene, suggesting that reversions may also
contribute to the rate difference in this gene, we find similar rate
differences for both pol and env. However, our study focuses on the
gp41 region of the env gene which may experience less reversions
compared to the C2V5 region of env gp120 for example.
By focusing on subtype C, our study extends the rate differences
within and among hosts that were previously established for
subtype B. However, the rate mismatch between the intra-host
and interhost level for epidemiologically unrelated patients
appears to be less pronounced (about 2-fold) than that identified
for subtype B complete genomes (about 4 to 5 fold difference,
[30]). This discrepancy may be due to the differences in the
transmission dynamics underlying subtype C and subtype B
spread. Based on a recent study that provided evidence against
preferential transmission from the compartmentalized virus [48],
and on rates of evolution that are even slower among IDUs than
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among populations where the virus is transmitted sexually [31],
Lythgoe et al. [28] claim that an inherent transmission and/or
establishment advantage is the most plausible hypothesis and
speculate that larger inoculum sizes during high-dose rectal and
intravenous transmission may result in slower among-host rates
than for sexual transmission. In the latter case, stochastic effects
may be more important. Following this argumentation, the less
pronounced rate mismatch we find for subtype C may be due to
the largely heterosexual nature of the this epidemic as opposed to a
larger contribution of homosexual and intravenous drug user
(IDU) transmission for subtype B. However, we note that a
comparison of six subtype B within-host data sets for the pol region
also pointed at lower differences (1.64 fold; [30]).
While the role of latently-infected memory T cells in creating a
long-term viral reservoir was already well established as a
significant barrier to HIV eradication [49], the ‘store and retrieve’
hypothesis also attributes a major role to HIV persistence and
reservoir dynamics in the conflict between HIV selective pressures
at the within and between host level. HIV evolution and
adaptation within a particular host has been termed ‘shortsighted’
because it is unlikely to favor viral variants that are efficiently
transmitted or that efficiently establish infection in new hosts [50].
The storage of HIV variants in latent cells at an early stage and
preferential transmission upon reactivation later in infection
provides a mechanism to respond to the different selective
pressures within and between hosts [51]. Further studies need to
determine how pervasive ‘store and retrieve’ can be because it has
important implications for modeling the spread of drug resistant
and immune escape variants. Our analysis of an HIV transmission
cluster using dedicated Bayesian inference approaches corrobo-
rates recent findings about rate differences within and among hosts
and hints at potential differences between different subtypes,
perhaps linked to differences in main risk group-associated
transmission routes.
Materials and Methods
Amplification, cloning and sequencing of the partial pol
and env gene regions from the HIV-1 subtype C
transmission chain samples
We obtained PCR products for both the pol and env gp41 region
(HXB2 nucleotide positions 2097 to 2292 and 7173 to 8792
respectively) using previously described procedures that were
specifically adapted for the use of Expand High Fidelity PCR
System (Roche Diagnostics, Mannheim, Germany) [52,53]. PCR
products from 25 samples were cloned using TOPO XL PCR
cloning kit (Life Technologies, Gent, Belgium), and 1–19 clones
were subsequently sequenced. TOPO ligated PCR fragments were
transformed into TOPO 10 cells (Life Technologies, Gent,
Belgium). Single colonies were used to inoculate 5 mL LB aliquots
and left overnight in a shaking incubator at 37uC. Plasmid DNA
was extracted from cultured cells using a QIAprep Miniprep Kit
(Qiagen, Venlo, The Netherlands) and clones were sequenced
using an ABI PRISM Big Dye Terminator v3.1 Ready Reaction
Cycle Sequencing Kit with previously described primer sets
[52,53]. Sequencing reactions were run on an ABI3100 Genetic
Analyzer (Life Technologies). Sequence fragments were assembled
and analyzed using Sequence Analysis v3.7 and SeqScape v2.0
(Life Technologies, Gent). For env in particular, the clone
sequences were considerably longer than the previously obtained
population sequences [18] because numerous insertions and
deletions seriously hamper unambiguous population sequencing
[53]. Testing both datasets for recombination signal with the W-
test [54] using SplitsTree v.4.12.6 [55] revealed significant
recombination signal (p=8.328E-5 for env and p=6.248E-4 for
pol. We omit sequences with statistically significant recombination
signal, as identified using RDP3 [56], from further analyses.
Bayesian evolutionary reconstruction of the HIV-1
subtype C transmission chain
Sequences were aligned using Clustal W [57] and manually
edited according to their codon reading frame in Se-Al (http://
tree.bio.ed.ac.uk). Because identical clones might have resulted
from template re-sampling [58], especially at lower viral loads, we
analyzed only unique sequences obtained from the isolates. We
conducted Bayesian evolutionary reconstructions using BEAST for
both the pol and env gp41 alignments employing either the Skyride
model [33] or the transmission model discussed below. The
Skyride model was used as a flexible demographic tree prior in
analyses aimed at testing molecular clocks and evaluating the
coalescent compatibility of viral genealogy with the known
transmission history, before enforcing this compatibility in analysis
using the transmission model. The latter is based on the
compatibility concept outlined below as the first part of the
transmission model, and formalized into a compatibility statistic.
Specifically, we record a statistic for each transmission in each
sampled genealogy that evaluates whether the source-recipient
coalescent events pre-date the specific transmission event and
whether the correct host transition order can be superimposed
onto the viral genealogy, allowing us to calculate the posterior
compatibility probability for each transmission event. We perform
our analyses with a codon position partitioning into first+second
and third positions, each associated with a general-time reversible
(GTR) model and among site rate heterogeneity modeled using a
discrete C-distribution and a proportion of invariable sites. We
apply the same substitution model and among-site rate variability
to the data discussed in the next sections. MCMC chains were run
sufficiently long to ensure convergence, as inspected using Tracer
v1.5 (http://tree.bio.ed.ac.uk). Maximum clade credibility (MCC)
trees were summarized using the TreeAnnotator tool in BEAST
and visualized in FigTree v1.4 (http://tree.bio.ed.ac.uk). Molec-
ular clock models, including a strict clock assumption as well as the
uncorrelated relaxed clock models with underlying exponential
(uced) and lognormal distribution (ucld), were tested using recent
implementations of path sampling (PS) [59] and stepping-stone
(SS) sampling [60] estimators of the marginal likelihood in BEAST
[35]. Both PS and SS have been shown to outperform the widely-
used harmonic mean estimators [35] and offer similar perfor-
mance as Bayesian model averaging when proper priors are used
[36]. The length of each power posterior MCMC length in the
PS/SS approach was set to he number of states for the standard
MCMC analysis divided by the number of steps taken to arrive at
the prior.
A Bayesian evolutionary model for known HIV-1
transmission histories
We implement a new genealogical model in the BEAST
statistical inference software [61] that accounts for the known
transmission links among patients and allows estimating evolu-
tionary parameters as well as transmission times and within-host
population dynamics from viral diversity sampled through time.
BEAST infers rooted, time-calibrated genealogies with a coales-
cent or birth-death process as a prior distribution for the
branching events [61]. Generally, the entire genealogy is assumed
to be generated by a single coalescent or branching process. To
accommodate the specific transmission structure and within-host
population dynamics, we modify this standard prior specification
HIV-1 Evolutionary Rate within and among Hosts
PLOS Computational Biology | www.ploscompbiol.org 11 April 2014 | Volume 10 | Issue 4 | e1003505
in two ways. First, we enforce the viral genealogy to be compatible
with the known transmission history by enforcing coalescent events
between source and recipient lineages to exist before the
transmission time and assuming a transmission-associated
source-recipient host transition along the relevant lineages in the
viral genealogy. In Figure 1, we illustrate the coalescent
compatibility concept for a hypothetical transmission chain of 4
patients and a particular genealogy of viruses sampled from each
patient. For each transmission event, we show an upper and lower
boundary for the transmission event which represents the fact that
the actual transmission time is difficult to pinpoint, but a
transmission interval can often be defined using external
information (e.g. based on the last negative and first HIV positive
test for the recipient). In this case, we require the coalescent times
for source and recipient lineages to predate the upper boundary
for the transmission time and superimpose transmission-associated
host transitions onto the viral genealogy as depicted by the
transitions in branch colors in Figure 1. The latter allows tracking
the host transition history in the viral genealogy and ensures that
also inadequate clustering of patient-specific lineages can lead to
incompatibility despite the fact the relevant coalescent times may
still be compatible with their transmission time (as observed for the
patient H and I lineages in the pol genealogy in the subtype C
transmission cluster). In the example genealogy, both the
coalescent events for lineages from patient 1 and patient 2, and
from patient 2 and patient 3, are compatible with their
transmission events, despite the fact that two lineages are
transmitted during the latter event. In contrast, the most recent
common ancestor for lineages from patient 3 and patient 4
appears to be more recent than the upper boundary for the
transmission time between patient 3 and patient 4, which is
considered to be incompatible under our model. Therefore, no
genealogies would be allowed to have such coalescent patterns
under the transmission constraints.
We explicitly parameterize the transmission times for each
transmission event and integrate out their dates over the known
transmission time intervals in our inference framework. The
transmission time parameters naturally partition the genealogy
into patient-specific lineages represented by the different branch
colors in Figure 1. This allows us to model a within-host coalescent
process for each patient and estimate population parameters based
on the distribution of waiting times in the patient-specific lineages.
Because within-host sampling is generally sparse for transmission
clusters, all patients share the same coalescent model in the current
implementation of the model, except maybe for the ultimate
source of the transmission cluster which cannot be related to its
respective source patient. We consider simple demographic
functions as coalescent models, including constant population size:
NRe (t)~N
R
e (tS?R),
where NRe (t) is the effective population size in the recipient (R) at
time t and Ne(tS?R) is the effective population size at time of
transmission (tS?R) from the source (S) to R. Because this model
assumes no transmission bottleneck (NRe (tS?R)~N
S
e (tS?R)),
where NSe (tS?R) is the effective population size in S at tS?R),
we also consider an exponential growth model:
NRe (t)~pN
S
e (tS?R)exp½{r(tS?R{t),
where p represents an ancestral proportion (0wpw1) of the
effective population size in S at time of transmission and r
represents the exponential growth rate, and extend this further to a
logistic growth model:
NRe (t)~
pNSe (tS?R)c
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,
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{1){1
 
r
)
2
664
3
775:
So, the latter two demographic functions are explicitly
parameterized in terms of a transmission bottleneck. Because this
cannot be applied to the patient at the origin of the transmission
chain (e.g. patient 1 in Figure 1), we allow specifying a separate
demographic function for this patient using standard parametric
formulations. Although constant, exponential and logistic models
can therefore also be applied to this patient, we consistently opted
for a simple constant model because the putative source patients
are only sparsely sampled through time (see Figure S1). Our
BEAST implementation enables the simultaneous inference of
viral genealogical history, including the tempo and mode of viral
evolution, and transmission times and bottlenecks. We sample
from the posterior distribution using Markov chain Monte Carlo
(MCMC) incorporating standard transition kernels.
Comparing estimates of within and among host
evolutionary rates for the subtype C transmission cluster
data
In order to compare evolutionary rate estimates at different
scales, we distinguish between HIV-1 evolution within hosts,
among epidemiologically-related hosts and among epidemiologi-
cally unrelated hosts. We study the first two processes based on
data from the subtype C transmission cluster and discuss the data
and associated analysis for the remaining evolutionary scale in the
next section. To obtain a ‘pure’ within-host evolutionary rate
estimate for pol and env gp41 across different patients, we apply a
Bayesian Hierarchical Phylogenetic (HPM) model to the trans-
mission cluster patients for which sequences from multiple time
points are available (see Table S2) [62,63]. This approach allows
specifying independent genealogies for each patient while pooling
information on evolutionary and population genetic parameters
across patients through hierarchical prior specification. Due to the
sparse sampling within the patients, we resort to a strict molecular
clock model and apply a constant population size model to the
patient-specific genealogy. We specify hierarchical prior distribu-
tions over the evolutionary rate and demographic parameters,
allowing them to vary around an unknown common mean. We
consider the mean estimate of the hierarchical prior distribution
for the evolutionary rate as a quantification of the overall within-
host evolutionary rate. To reduce the impact of within-host
evolution among the epidemiologically-related patients, we only
include the time point of each patient closest to the transmission
event from its source.
Because HIV-1 replication rate and evolutionary rate may be
affected by drug treatment, which was common for the patients in
our subtype C transmission chain, we sought to investigate how
comparable our within-host rate was to estimates from untreated
patients. For this purpose, we compiled control data sets based on
a search for intra-patient sequences in the HIV sequence database
(http://www.hiv.lanl.gov/) according to the following criteria: (i)
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longitudinal samples, (ii) known time of sampling, (iii) untreated,
(iv) pol or env genome region, including fragments with a minimum
length of 200. By screening the relevant publications, we identified
10 and 15 studies with pol and env data respectively that met our
criteria. To ensure a close match in genomic region, all sequence
data were aligned against the clonal data. Only sequences with .
75% overlap with the clonal data of the respective region were
kept for further analysis. Because only few pol sequences (9/30
patients) spanned the entire length of the clonal sequence
alignment, we trimmed the alignment from 421 AA to 330 AA
( = 78.5% of the original length). Finally, duplicates were removed
and sequences were grouped per patient. This resulted in the
inclusion of 30 patients for which the serially-sampled sequences
start at AA 1 of protease and end at AA 231 of reverse
transcriptase (numbering according to HXB2). For env, where the
sequence overlap was less of an issue, the intermediate alignment
consisted of 34 patients and comprised AA 468 to AA 856 of
gp160. We refer to Tables S7 and S8 for a detailed overview of all
control datasets.
In addition to serving as untreated controls, both the pol and env
data sets were stratified in those sampled during ‘early’ and
‘chronic’ stage of infection by making use of the available disease
stage information, in order to assess what impact this has on
substitution rates estimates. In particular we classified sequences
under ‘early’ when they were sampled in the first year of infection
and ‘chronic’ when they were sampled later in infection. The data
from the subtype C transmission chain corresponds better with
data from the chronic stage of infection, which generally also
allows for sampling over longer time periods providing potentially
more calibration information. Following the within-host evolu-
tionary analysis for transmission chain patients, we apply a
Bayesian HPM procedure to this data, but extend it with fixed
effects to test for differences among patient groups [63]. The fixed-
effects HPM enables the estimation of Bayes Factor (BF) support
for the early vs. chronic group effect on any evolutionary
parameter, in our case the evolutionary rate.
Evolutionary rate estimation for epidemiologically-
unlinked subtype C sequence data
To complement our rate estimates within hosts and among
epidemiologically-linked hosts, we compile a representative
subtype C data set from epidemiologically-unlinked hosts. To this
purpose, we retrieve and align all available HIV-1 subtype C full
genomes with annotated sampling year from the Los Alamos HIV
sequence database (http://www.hiv.lanl.gov/). From the resulting
alignment containing 505 sequences, we select a diverse subset to
minimize epidemiological relatedness and ensure that they are
representative for the diversity of the subtype C epidemic. At the
same time, we aim to spread the sampling density over the
available sampling time interval. Therefore, we select the 5 most
divergent sequences within each sampling year by constructing a
BioNJ tree in Seaview [64], followed by subsampling according to
diversity. For the latter we make use of the Phylogenetic Diversity
algorithm, which selects for the subtree of n taxa connected by the
longest branch length [65]. For the year 1989, we kept only two
sequences in our selection because 3 of the 4 available sequences
were from the same patient. This selection procedure resulted in a
dataset of 82 taxa spanning the period of 1986–2010. Inspection of
the temporal signal by plotting root-to-tip divergence as a function
of sampling time in Path-O-Gen v1.3 (http://tree.bio.ed.ac.uk/)
lead us to remove 1 outlier sequence from 2009, and showed clear
signal for divergence accumulation over the sampling time interval
(R2= 0.50) for the remaining 81 full genomes. We again used the
W-test [54] as implemented in SplitsTree v4.12.6 [55] to detect
recombination; no significant signal was found.
For the Bayesian genealogical inference, we partition the full
genome by gene to allow for among-gene rate variation. We
further subdivide the rev and tat genes according to their splicing
parts, and split pol and env into the region that overlaps with our
clonal data and the remainder of the gene. We specify a Bayesian
HPM for the gene-specific GTR substitution model parameters,
the shape parameter for C-distribution modeling among-site rate
variation, and for the proportion of invariant sites. Similar to the
analyses of the other data sets, we specify a Bayesian Skyride
model as a flexible demographic prior for the tree.
A mixed effects molecular clock to model among-lineage
evolutionary rate variation
To quantify and test for different evolutionary rates along an
arbitrary branch set in the genealogy, we develop a novel mixed
effects molecular clock approach in our Bayesian framework that
combines both fixed and random effects. Following standard
hierarchical modeling terminology, the random effects hi quantify
possibly different rates for each branch i and we posit that these
effects arise from an uncorrelated relaxed clock process following
[34] on the log-scale. Assuming effects are additive on the log-
scale, we further incorporate fixed effects b to allow for different
overall rates on fixed subset of branches in the unknown
genealogy. Specifically, we model the overall rate ri on branch i as
log ri~hizXib, ð1Þ
where Xi is the fixed design indicator or covariate associated with
branch i.
We test two different fixed-effect designs for the transmission
chain data: one that differentiates branches along which a
transmission event occurred from the remaining branches and
one that differentiates the branches representing the transmitted
lineage from the remaining branches (see Figure S5). In the former
case, we focus on single branches that unequivocally represent a
transmission event. For these branches, we set Xi~1; for all other
branches, we set Xi~0. To achieve unequivocal events, we omit
the sequence samples from patient G and the earliest sampling
time point for patient C (C94), which complicate the unambiguous
assignment of transmission events. The remaining nine transmis-
sion-associated branches are generally well-supported in the
posterior according to the genealogical inference, but we enforce
the descendent taxa to be monophyletic in the molecular clock
inference to ensure that the effect is always associated with an
identifiable branch. For the second approach, we specify
‘transmitted’ lineages for the full data set without monophyletic
constraints as the set of branches from the root of the tree to the
MRCAs of patients from which there is no more onwards
transmission in the chain; these branches receive Xi~1 and
represent the ‘trunk’ or ‘backbone’ lineages [47] for multiple
patients in a transmission chain.
To evaluate the significance of the fixed-effect specification, we
conduct a Bayes factor (BF) test [66] that expresses the posterior
odds over the prior odds that rates on the branches of interest
(transmission-associated or transmission lineage-associated) are
lower than the background within-host branches. We perform the
BF test using the posterior sample obtained via MCMC directly
since the restricted hypothesis is nested within the unconstrained
model that we simulate. Under the unconstrained model, the
posterior sample average of the indicator I(bv0) converges to the
posterior probability of the constrained hypothesis. Since the prior
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odds in our case simplify to 1, we simply need to compute the odds
ratio of the mean indicator value to estimate the BF.
Estimating absolute rates of synonymous and non-
synonymous substitutions at the different evolutionary
scales
To estimate absolute synonymous and non-synonymous substi-
tution rates, we integrate recently developed stochastic mapping
procedures in the BEAST analyses described above [40]. We
follow an approach that is conceptually similar to [47], but is
computationally more efficient in accommodating the uncertainty
about the phylogenetic tree and about other nuisance parameters.
Briefly, we fit codon position partitioned substitution models in a
Bayesian framework and use standard MCMC integration to
obtain a sample from the posterior distribution of model
parameters. At each iteration of the MCMC, we use stochastic
mapping to impute the full evolutionary history of each nucleotide
position within each codon site in our alignment and subsequently
summarize the resulting numbers synonymous (S) and non-
synonymous (N) substitutions. To obtain posterior estimates of
synonymous (mS ) and non-synonymous (mN ) evolutionary rates in
substitutions per site per year, we divide the total S and N counts
at each iteration by the total tree length in time units, and
summarize these quantities across the posterior distribution of
trees to arrive at mean estimates and credible intervals. To obtain
an overall within-host mS and mN estimate for comparison with the
estimates for the epidemiologically-linked and epidemiologically-
unrelated data sets, we sum the N and S counts for the patient-
specific genealogies at each iteration in the HPM analysis and
divide them by the sum of the respective tree lengths, and then also
summarize these quantities across all samples.
Supporting Information
Figure S1 Schematic representation of the studied
transmission chain. Orange arrows indicate transmission
events. The width of the arrow is proportional to the time interval
for transmission. For the first event between patient A and B, the
time and direction of transmission could not be established by the
patient interviews nor by clinical data. This is indicated by the
double-sided arrow. The patients are indicated by bars whereby
the color indicates the treatment status. Red indicates periods
without treatment whereas the treatment type is as in the legend.
{: the patient is deceased. The light blue arrows indicate sampling
events for which clonal data were generated, including the
sampling year.
(EPS)
Figure S2 Maximum clade credibility tree for pol. Tips
and internal branches are colored according to the states posterior
probability as estimated using a non-reversible discrete asymmetric
trait analysis with the patients as discrete states [67,68]. This was
run on the empirical tree distribution obtained with the Skyride
analysis of our chain data. The correspondence between the colors
and patients is as in the legend. Numbers indicate the posterior
probability of the nodes.
(EPS)
Figure S3 Maximum clade credibility tree for pol after
exclusion of the same drug resistance associated
positions as in [18]. Tips and internal branches are colored
according to the states posterior probability as estimated using a
non-reversible discrete asymmetric trait analysis with the patients
as discrete states [67,68]. This was run on the empirical tree
distribution obtained with the Skyride analysis of our chain data.
The correspondence between the colors and patients is as in the
legend. Numbers indicate the posterior probability of the nodes.
(EPS)
Figure S4 Maximum clade credibility tree for env. Tips
and internal branches are colored according to the states posterior
probability as estimated using a non-reversible discrete asymmetric
trait analysis with the patients as discrete states [67,68]. This was
run on the empirical tree distribution obtained with the Skyride
analysis of our chain data. The correspondence between the colors
and patients is as in the legend. Numbers indicate the posterior
probability of the nodes.
(EPS)
Figure S5 Illustration of the fixed-effects rate specifica-
tion using env as an example. Branches on which the rate
effect is specified are coloured red. A) The rate effect is specified on
the branches over which transmission could unambiguously be
assigned. B) The fixed-effects are specified on the branches that
represent the transmitted lineages.
(EPS)
Figure S6 Illustration of the effect of the transmission-
associated rate decline on node height estimation under
a molecular clock model. Each tree depicts the same
hypothetical transmission scenario. The transmission event is
represented by the transition from black (source) to red (recipient)
along the relevant branch. Branch lengths for the left and middle
tree are expressed in units of genetic change, whereas they
represent time for the tree on the right. The leftmost tree depicts
the situation that can be expected under a constant evolutionary
rate throughout the evolutionary history, i.e. when the divergence
between source and recipient taxa is proportional to their
divergence time. The tree in the middle illustrates that
transmission of an ancestral variant (the branch part in the source
has been evolving at a slower rate) results in a lower then expected
divergence. However, under a clock model tips are constrained to
be proportional to their sampling time and because of the
averaging effect of rate differences under an uncorrelated relaxed
clock - rates are drawn from an underlying distribution- the lower
divergence between the source and recipient lineages will be
reflected in a more recent divergence time for their common
ancestor (rightmost tree).
(EPS)
Table S1 Established transmission intervals. Samples are
indicated by a capital letter to identify the patient, followed by two
numbers to indicate the sampling year. If different from the
number of sequenced clones, the number of unique sequences is
indicated between brackets.
(PDF)
Table S2 Overview of the conal data. Samples are indicated
by a capital letter to identify the patient, followed by two numbers
to indicate the sampling year. If different from the number of
sequenced clones, the number of unique sequences is indicated
between brackets.
(PDF)
Table S3 Molecular clock model comparison for the pol
and env sequences. 1 PS: path sampling log marginal likelihood
estimates. SS: stepping stone sampling log marginal likelihood
estimates. Smaller absolute values indicate a better model fit. The
similarity between the marginal likelihoods estimated by path
sampling (PS) and stepping-stone sampling (SS) suggests adequate
convergence properties [35,36]. 2 uced and ucld: uncorrelated
relaxed clock models in which the rate of every branch is drawn
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from an underlying exponential (uced) or lognormal (ucld)
distribution.
(PDF)
Table S4 Demography model comparison results for
the pol and env region. 1 PS: path sampling log marginal
likelihood estimates. SS: stepping stone sampling log marginal
likelihood estimates. Smaller absolute values indicate better model
fit. The similarity between the marginal likelihoods estimated by
path sampling (PS) and stepping-stone sampling (SS) suggests
adequate convergence properties [35,36].
(PDF)
Table S5 Fixed effects analyses. 1 Bayes factors (BF) indicate
how much the posterior (the result) deviates from the prior (the
initial beliefs). In general, BF ,3 are considered as absence of
support. 2 These results refer to the comparison of the within host
rate of the transmission chain subjects with the within host rate of
the control patients. 3 Here, the within host rate estimates of the
‘early’ group (only control subjects) are weighed against the rate
estimate of the ‘late’ group (both control and transmission chain
patients).
(PDF)
Table S6 Evolutionary rate estimates and support for
the fixed effect in the mixed effects clock model using a
flexible coalescent prior. Whereas the estimates in Table 2
were obtained under the transmission model, the estimates in this
table were obtained using the Bayesian skyride model as a tree
prior. The mean evolutionary rate and highest posterior density
(HPD) intervals are expressed as the number of nucleotide
substitutions (1023) per site per year. The Bayes factor (BF) is
computed as the posterior odds over the prior odds that the rate
for the transmission branches or transmitted lineage branches is
smaller than the within host-rate.
(PDF)
Table S7 Detailed information on the pol within host
rate control data sets. 1 median number of time points: 7
(range: 2–12). Median time period covered: 148 (range: 4–350). 2
median number of time points: 7 (range: 3–19). Median time
period covered: 1170 (range: 434–4352). 3 When all samples were
taken within the first year after the known or estimated date of
infection, the sampled disease stage is labeled ‘early’. When later
samples were available, the sampled disease stage is labeled as
‘chronic’. 4 All sample dates were, if not yet specified as such,
converted to days. Whenever the date was specified as mm-yyyy
instead of dd-mm-yyyy, the day was set tot the 15th. When the
sampling date was only specified as a year, the data were not taken
into account.
(PDF)
Table S8 Detailed information on the env within host
rate control data sets. 1: median number of time points: 5,5
(range: 2–12). Median time period covered: 184 (range: 4–341). 2:
median number of time points: 6,5 (range: 3–11). Median time
period covered: 1118 (range: 1142–3661). 3,4 Determination of the
‘early’ and ‘chronic’ stages as well as the dating were done in the
same manner as for the pol data. The sample date for the siblings
studied by Draenert et al. [69] was given as months after infection.
Here, the conversion was done by assuming 30 days per month. 5:
Additional sequences for this patient were available from [70]. 6:
Additional sequences for this patient were available from [71] and
[3]. 7: Additional sequences for this patient were available from
[71].
(PDF)
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